Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
INP
iPath ETNs Linked to the MSCI India Total Return Index
INP
|
+$1.36B |
| 2 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$236M |
| 3 |
Apple
AAPL
|
+$223M |
| 4 |
State Street Utilities Select Sector SPDR ETF
XLU
|
+$222M |
| 5 |
Southern Company
SO
|
+$182M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
FON
SPRINT CORP FON COM
FON
|
+$724M |
| 2 |
Pfizer
PFE
|
+$469M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$409M |
| 4 |
iShares US Real Estate ETF
IYR
|
+$407M |
| 5 |
Zoetis
ZTS
|
+$215M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 4.63% |
| 2 | Healthcare | 4.25% |
| 3 | Technology | 4.18% |
| 4 | Energy | 3.42% |
| 5 | Communication Services | 3.3% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3576
MKS Inc
MKSI
$20.6B
| $770K | ﹤0.01% |
29,597
-14,031
| -32% | -$375K |
|
|
AV
3577
DELISTED
Aviva Plc
AV
| $770K | ﹤0.01% |
64,207
+21,973
| +52% | +$265K |
|
3578
CALL
Nektar Therapeutics
NKTR
$2.58B
| $768K | ﹤0.01% |
5,120
+3,060
| +149% | +$566K |
|
3579
CALL
Travel + Leisure Co
TNL
$4.7B
| $768K | ﹤0.01% |
28,352
-31,232
| -52% | -$855K |
|
|
VSI
3580
DELISTED
Vitamin Shoppe Inc.
VSI
| $766K | ﹤0.01% |
17,809
-25,985
| -59% | -$1.15M |
|
|
DNKN
3581
CALL
DELISTED
Dunkin' Brands Group, Inc.
DNKN
| $765K | ﹤0.01% |
17,000
-17,200
| -50% | -$754K |
|
3582
Hope Bancorp
HOPE
$1.79B
| $762K | ﹤0.01% |
58,621
-5,294
| -8% | -$76.2K |
|
3583
PUT
Public Service Enterprise Group
PEG
$37.7B
| $762K | ﹤0.01% |
23,800
+9,300
| +64% | +$308K |
|
|
UFS
3584
DELISTED
DOMTAR CORPORATION (New)
UFS
| $762K | ﹤0.01% |
19,300
+7,890
| +69% | +$280K |
|
3585
BlackRock Enhanced Captial and Income Fund
CII
$1.02B
| $760K | ﹤0.01% |
63,344
-64,904
| -51% | -$842K |
|
3586
PUT
Clean Harbors
CLH
$16.3B
| $760K | ﹤0.01% |
13,100
-19,700
| -60% | -$1.1M |
|
3587
Forum Energy Technologies
FET
$835M
| $760K | ﹤0.01% |
1,408
+132
| +10% | +$73.8K |
|
3588
LiveRamp
RAMP
$2.3B
| $760K | ﹤0.01% |
27,117
+5,841
| +27% | +$150K |
|
|
TEP
3589
DELISTED
Tallgrass Energy Partners, LP
TEP
| $760K | ﹤0.01% |
33,059
+7,267
| +28% | +$163K |
|
|
TLAB
3590
DELISTED
TELLABS INC
TLAB
| $760K | ﹤0.01% |
380,407
-19,527
| -5% | -$44.2K |
|
|
AMED
3591
CALL
DELISTED
Amedisys
AMED
| $758K | ﹤0.01% |
44,600
+32,600
| +272% | +$484K |
|
|
HOLX
3592
CALL
DELISTED
Hologic
HOLX
| $758K | ﹤0.01% |
37,900
-7,900
| -17% | -$168K |
|
3593
CALL
Sturm, Ruger & Co
RGR
$593M
| $756K | ﹤0.01% |
12,200
-15,100
| -55% | -$812K |
|
|
IPXL
3594
DELISTED
Impax Laboratories, Inc.
IPXL
| $755K | ﹤0.01% |
37,715
-12,511
| -25% | -$258K |
|
3595
PUT
BCE
BCE
$21.2B
| $752K | ﹤0.01% |
17,900
-3,100
| -15% | -$129K |
|
|
KSU
3596
PUT
DELISTED
Kansas City Southern
KSU
| $752K | ﹤0.01% |
6,900
-9,200
| -57% | -$1.01M |
|
|
VER
3597
DELISTED
VEREIT, Inc.
VER
| $752K | ﹤0.01% |
12,537
+10,713
| +587% | +$730K |
|
|
MBFI
3598
DELISTED
MB Financial Corp
MBFI
| $752K | ﹤0.01% |
26,829
-20,590
| -43% | -$580K |
|
|
CRZO
3599
CALL
DELISTED
Carrizo Oil & Gas Inc
CRZO
| $751K | ﹤0.01% |
20,300
-117,300
| -85% | -$3.9M |
|
3600
Encompass Health
EHC
$12.4B
| $749K | ﹤0.01% |
27,692
+4,179
| +18% | +$107K |
|
Similar funds
Barclays's Q3 2013 Portfolio in Review
As of Q3 2013, Barclays held 8,017 positions worth $83.8B, up 4.2% from $80.4B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Barclays's Q3 2013 filing shows 302 new, 3,328 increased, 3,470 reduced and 580 closed positions. Its largest new stake was Twenty-First Century Fox, Inc. Class A: 2,167,568 shares worth $71.5M. The largest sale was SPRINT CORP FON COM, an estimated $724M.
By sector, the portfolio is most concentrated in Financials at 4.6% of assets, up from 4.5% a quarter earlier, followed by Healthcare and Technology.
- Barclays's largest Q3 2013 buy was Twenty-First Century Fox, Inc. Class A: 2,167,568 shares worth $71.5M.
- Barclays added most to iPath ETNs Linked to the MSCI India Total Return Index in Q3 2013, an estimated $1.36B increase.
- Barclays's biggest Q3 2013 reduction was Pfizer, cutting an estimated $469M.
- Barclays fully exited SPRINT CORP FON COM in Q3 2013, selling an estimated $724M.
- Barclays's ten largest holdings make up 26% of its $83.8B portfolio in Q3 2013.
- Barclays opened 302 new positions and closed 580 in Q3 2013.
- Barclays's portfolio value rose 4.2% quarter-over-quarter to $83.8B.
Based on Barclays's 13F filing for Q3 2013, filed 14 Nov 2013.